Investing, Stocks, Stocks to Buy

Abbott’s Yield Is Near 3%. Is This a Rare Opportunity?

Rick Orford Written by: Rick Orford
Mike Reyes Edited by: Mike Reyes
Last Updated May 1, 2026
Disclaimer

This content is not intended to provide financial advice; rather, it’s for information and entertainment purposes only.

Always consult a licensed advisor for investment decisions.

Some of the links in this article may be affiliate links. If you click on a link, the affiliate may provide compensation to this site at no cost to you, regardless if you decide to purchase something. You can read our affiliate disclosure in our privacy policy.

Finally, this article has been written, reviewed, and fact-checked. Portions of this article have been written using assistive AI tools to help with tasks like research, spell-checking, grammar, and translation. Please have a look at our editorial guidelines for more information about how we create content.

Abbott (NYSE:ABT) is giving income investors a rare setup: a Dividend King yield approaching 3% while the business continues to grow. The stock has been under pressure as COVID testing normalized, but medical devices, dividend consistency, and steady operating performance may make the story more interesting than the market suggests.

Stock prices used were the market prices of April 27, 2026. The video was published on April 30, 2026. On the date of publication, Rick Orford did not have (either directly or indirectly) positions in any of the securities mentioned in this video.

15585

You Found Me :)

Now Let's Grow Your Wealth

Learn to invest like the pros—even if you're just starting.

15856